Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

1.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

228
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
228
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

292
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
292
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

2.3K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.3K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

WTAP tetramer ensures m<sup>6</sup>A writer assembly and faithful mitosis.

EMBO reports·2026
Same author

Structural insights into the Nipah virus nucleocapsid assembly.

Communications biology·2026
Same author

Structure of Crimean-Congo haemorrhagic fever virus RNA polymerase.

Nature microbiology·2026
Same author

mRNA vaccination targeting AML1::ETO fusion gene eliminates leukemia cells via activating T cells.

Leukemia·2026
Same author

Overcoming the challenge of preferred particle orientation in cryo-EM.

Nature reviews. Molecular cell biology·2026
Same author

Structures of Marburgvirus glycoprotein and its complex with NPC1 receptor.

Nature·2026

関連する実験動画

Updated: Jun 30, 2025

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

3.3K

膀性モノアミンの貯蔵と薬物相互作用に関する構造的洞察

Jin Ye1, Huaping Chen2, Kaituo Wang3

  • 1Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St Louis, MO, USA.

Nature
|March 18, 2024
PubMed
まとめ

膀性モノアミントランスポーター (VMAT) は神経伝達物質を貯蔵し,神経細胞を保護する. 新しい冷凍-EM構造がVMAT1を明らかにする

さらに関連する動画

An Optical Assay for Synaptic Vesicle Recycling in Cultured Neurons Overexpressing Presynaptic Proteins
09:33

An Optical Assay for Synaptic Vesicle Recycling in Cultured Neurons Overexpressing Presynaptic Proteins

Published on: June 26, 2018

7.5K
Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

9.9K

関連する実験動画

Last Updated: Jun 30, 2025

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

3.3K
An Optical Assay for Synaptic Vesicle Recycling in Cultured Neurons Overexpressing Presynaptic Proteins
09:33

An Optical Assay for Synaptic Vesicle Recycling in Cultured Neurons Overexpressing Presynaptic Proteins

Published on: June 26, 2018

7.5K
Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

9.9K

科学分野:

  • 神経科学
  • 構造生物学
  • 生物化学

背景:

  • 生物学的モノアミンは,膀性モノアミントランスポーター (VMAT) によって調節される重要な神経伝達物質である.
  • VMATは,陽子反ポートを通じてモノアミンの貯蔵と神経保護を促進しますが,その構造的メカニズムは十分に理解されていません.
  • VMATは神経変性疾患,高血圧,依存症の治療における重要な標的です.

研究 の 目的:

  • ヒトのVMAT1の構造的メカニズムを様々な基板と複合的に解明する.
  • VMATの輸送メカニズムと基板特異性についての洞察を提供する.

主な方法:

  • クリオ電子顕微鏡 (cryo-EM) を使用して,ヒトVMAT1の8つの構造を決定した.
  • 無結合のVMAT1およびモノアミン,MPP+,アンフェタミン,およびレザーピンとの複合体で構造が得られた.

主要な成果:

  • 人間のVMAT1の8つの冷凍-EM構造は,異なる形状 (細胞質-オープンと膜-オープン) を表しています.
  • モノアミンや神経毒薬は 特定の極点と多用途の形を持つ 共通のポケットに結合します
  • レザーピンの結合は細胞質の開かれた状態を誘導し,他の基板は輸送に不可欠な光の開かれた状態を安定させる.

結論:

  • 構造的な洞察は,膀性モノアミンの輸送とVMATゲーティングのメカニズムを明らかにします.
  • VMATの構造を理解することは,神経疾患と薬物乱用のための治療法の開発の基礎を提供します.